Hb. Saur et al., COMPARISON OF D2 RECEPTOR-BINDING (I-123- IBZM) AND RCBF (TC-99M-HMPAO) IN EXTRAPYRAMIDAL DISORDERS, Nuklearmedizin, 33(5), 1994, pp. 184-188
The aim of this SPECT study was to determine whether there is a correl
ation between rCBF (99mTc-HMPAO) and D2 receptor binding (123I-IBZM) i
n disorders of the extrapyramidal system and in which situation the 99
mTc-HMPAO scan could predict the outcome of the 123I-IBZM study. 13 pa
tients with Parkinson's syndrome and 13 patients with hyperkinetic ext
rapyramidal disorders were studied. In all patients the two SPECT stud
ies were performed within 2-7 days. ROIs were placed over the basal ga
nglia (BG), the frontal cortex (FC) and the cerebellum (CE). The ratio
s BG/FC and BG/CE were calculated. In both groups the scatter was lowe
r when the frontal cortex was used as reference region. Among the pati
ents with hyperkinetic extrapyramidal disorders the two patients with
Huntington's chorea had lower rCBF and D2 receptor binding compared to
other hyperkinetic extrapyramidal disorders. There was no correlation
between D2 receptor binding and rCBF in the basal ganglia. The 99mTc-
HMPAO studies did not provide clinically useful information, except in
Huntington's chorea.